Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?

Antibody dependent enhancement (ADE) of infection is a safety concern for vaccine strategies. In a recent publication, Li et al. (Cell 184 :4203–4219, 2021) have reported that infection-enhancing antibodies directed against the N-terminal domain (NTD) of the SARS-CoV-2 spike protein facilitate virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahi, Nouara, Chahinian, Henri, Fantini, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351274/
https://www.ncbi.nlm.nih.gov/pubmed/34384810
http://dx.doi.org/10.1016/j.jinf.2021.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351274/
https://www.ncbi.nlm.nih.gov/pubmed/34384810
http://dx.doi.org/10.1016/j.jinf.2021.08.010

Ejemplares similares